Beijing Haitian Ruisheng Science Technology Ltd.

SSE:688787.SS

95.81 (CNY) • At close May 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q12018 Q1
Revenue 69.8187.52657.13150.96139.62266.79628.75445.64328.81795.72852.37566.90847.87675.724.77561.76344.23990.640.83470.67831.261101.80631.24128.484
Cost of Revenue 36.71529.90722.19320.71211.41432.78111.37115.59615.04530.18223.94123.08415.50332.17911.20319.03411.89631.20719.33819.4645.36929.56311.8648.786
Gross Profit 33.09557.61934.93830.24928.20934.01617.38330.04813.77365.54728.43443.82432.37343.52113.57242.72932.34359.39421.49651.21425.89272.24319.37719.698
Gross Profit Ratio 0.4740.6580.6120.5940.7120.5090.6050.6580.4780.6850.5430.6550.6760.5750.5480.6920.7310.6560.5260.7250.8280.710.620.692
Reseach & Development Expenses 13.15620.54516.22112.14613.14112.71813.5615.28116.93330.13821.45424.74617.93521.47715.03714.0999.90814.87611.8189.8076.99641.69600
General & Administrative Expenses 13.643-32.61636.183-5.68613.031-39.57842.572-9.36915.602-18.50529.623-3.5339.59-15.91919.2530.8640.9940.869-9.14711.0040.85626.07200
Selling & Marketing Expenses 7.101-11.75715.4895.9484.9985.5196.1737.3334.85.1884.8895.1063.1795.1464.032.9582.3894.0672.9352.5271.6059.25300
SG&A 20.743-44.37351.67219.57120.003-34.05948.745-2.03620.403-13.31734.5111.57412.768-10.77423.2833.8233.3834.936-6.21313.5312.46242.93600
Other Expenses 0.15374.547-36.1280.035-0.065-0.1490.0790.512-2.81443.714-19.67215.918-4.730.1420.0070.1750.1131.9320.2030.363-0.020-13.327-7.277
Operating Expenses 34.05250.71831.76531.68233.20931.532.03540.22534.52260.53536.29342.23825.97439.49328.01120.10815.87625.71217.8216.79913.21833.131-13.327-7.277
Operating Income -0.9576.9013.172-1.432-5.0011.228-18.72-6.249-19.0376.788-7.8597.849.7765.8-13.99623.17118.4132.7965.62936.18315.60939.1996.0512.422
Operating Income Ratio -0.0140.0790.056-0.028-0.1260.018-0.651-0.137-0.6610.071-0.150.1170.2040.077-0.5650.3750.4160.3620.1380.5120.4990.3850.1940.436
Total Other Income Expenses Net -0.005-0.6460.1770.3954.394-0.1490.0790.5121.4852.7940.9982.9960.090.1420.0070.1750.1130.0430.2030.363-0.024.5320.028-0.002
Income Before Tax -0.9626.2553.3491.597-0.6071.079-18.641-5.737-17.5529.582-1.92410.8369.8665.942-13.9923.34618.52332.8395.83236.54615.5943.7316.07812.42
Income Before Tax Ratio -0.0140.0710.0590.031-0.0150.016-0.648-0.126-0.6090.1-0.0370.1620.2060.078-0.5650.3780.4190.3620.1430.5170.4990.430.1950.436
Income Tax Expense -1.1-1.277-0.0230.5470.027-0.656-3.763-2.112-3.936-1.241-1.1290.8480.428-0.005-1.8331.8732.1812.5770.6143.5991.9364.2530.6881.158
Net Income 0.3727.5473.3721.051-0.6341.735-14.878-3.625-13.61610.823-0.7959.9889.4385.947-12.15721.47316.34230.2625.21832.94713.65439.4785.3911.262
Net Income Ratio 0.0050.0860.0590.021-0.0160.026-0.517-0.079-0.4730.113-0.0150.1490.1970.079-0.4910.3480.3690.3340.1280.4660.4370.3880.1730.395
EPS 0.010.1260.0570.021-0.0110.019-0.25-0.06-0.230.18-0.0190.230.220.14-0.280.50.360.940.161.030.310.880.120.27
EPS Diluted 0.010.1260.0570.021-0.0110.019-0.25-0.06-0.230.18-0.0190.230.220.14-0.280.50.360.940.161.030.310.880.120.27
EBITDA -0.8986.3133.4146.5681.5814.963-16.183-1.875-20.24611.5850.07212.69811.7367.694-13.95725.27220.51134.4595.61534.41513.45439.8256.37819.698
EBITDA Ratio -0.0130.0720.060.1290.040.074-0.563-0.041-0.7030.1210.0010.190.2450.102-0.5630.4090.4640.380.1380.4870.430.3910.2040.692